Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

K. Takahashi, E. Jabbour, X. Wang, R. Luthra, C. Bueso-Ramos, K. Patel, S. Pierce, H. Yang, Y. Wei, N. Daver, S. Faderl, F. Ravandi, Z. Estrov, J. Cortes, H. Kantarjian, G. Garcia-Manero

Research output: Contribution to journalLetterpeer-review

45 Scopus citations
Original languageEnglish (US)
Pages (from-to)2081-2083
Number of pages3
Issue number10
StatePublished - Oct 2013
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this